Prognostic Factors and Risk-Adapted Therapy in Patients With Early Stage Chronic Lymphocytic Leukemia
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Fludarabine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.
- 08 Dec 2007 Results reported at ASH 2007
- 05 Sep 2006 New trial record.